Adenosine dysfunction in epilepsy

GLIA

Volumn 60, Issue 8, 2012, Pages 1234-1243

  Boison, Detlev ^a  

^a LEGACY RESEARCH   (United States)

Author keywords

Adenosine; Adenosine kinase; Astrogliosis; Epilepsy; Homeostasis

Indexed keywords

ADENOSINE; ADENOSINE KINASE; ADENOSINE RECEPTOR;

ADENOSINE DYSFUNCTION; ARTICLE; ASTROCYTE; ASTROCYTOSIS; BIOENERGY; ENZYME DEFICIENCY; EPIGENETICS; EPILEPSY; EPILEPTOGENESIS; GENE THERAPY; HIPPOCAMPAL SCLEROSIS; HUMAN; IMMUNOMODULATION; KETOGENIC DIET; METABOLIC DISORDER; NONHUMAN; PRIORITY JOURNAL; SEIZURE; TEMPORAL LOBE EPILEPSY;

ADENOSINE; ADENOSINE KINASE; ANIMALS; DISEASE MODELS, ANIMAL; EPILEPSY; HUMANS; METABOLIC DISEASES; PHOSPHORYLATION;

EID: 84862317564     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.22285     Document Type: Article

References (80)

1. Anschel DJ, Ortega EL, Kraus AC, Fisher RS. 2004. Focally injected adenosine prevents seizures in the rat. Exp Neurol 190: 544-547.
2. Aronica E, Zurolo E, Iyer A, de Groot M, Anink J, Carbonell C, van Vliet EA, Baayen JC, Boison D, Gorter JA. 2011. Upregulation of adenosine kinase in astrocytes in experimental and human temporal lobe epilepsy. Epilepsia 52: 1645-1655.
3. Baldwin SA, Beal PR, Yao SY, King AE, Cass CE, Young JD. 2004. The equilibrative nucleoside transporter family, SLC29. Pflugers Arch 447: 735-743.
4. Bell B, Lin JJ, Seidenberg M, Hermann B. 2011. The neurobiology of cognitive disorders in temporal lobe epilepsy. Nat Rev Neurol 7: 154-164.
5. Benarroch EE. 2008. Adenosine and its receptors: Multiple modulatory functions and potential therapeutic targets for neurologic disease. Neurology 70: 231-236.
6. Boison D. 2005. Adenosine and epilepsy: From therapeutic rationale to new therapeutic strategies. Neuroscientist 11: 25-36.
7. Boison D. 2008. The adenosine kinase hypothesis of epileptogenesis. Progr Neurobiol 84: 249-262.
8. Boison D, Chen JF, Fredholm BB. 2010. Adenosine signalling and function in glial cells. Cell Death Differ 17: 1071-1082.
9. Boison D, Scheurer L, Zumsteg V, Rülicke T, Litynski P, Fowler B, Brandner S, Mohler H. 2002. Neonatal hepatic steatosis by disruption of the adenosine kinase gene. Proc Natl Acad Sci USA 99: 6985-6990.
10. Brambilla R, Cottini L, Fumagalli M, Ceruti S, Abbracchio MP. 2003. Blockade of A2A adenosine receptors prevents basic fibroblast growth factor-induced reactive astrogliosis in rat striatal primary astrocytes. Glia 43: 190-194.
11. Clark RS, Carcillo JA, Kochanek PM, Obrist WD, Jackson EK, Mi Z, Wisneiwski SR, Bell MJ, Marion DW. 1997. Cerebrospinal fluid adenosine concentration and uncoupling of cerebral blood flow and oxidative metabolism after severe head injury in humans. Neurosurgery 41: 1284-1292; discussion 1292-1293.
12. Cui XA, Singh B, Park J, Gupta RS. 2009. Subcellular localization of adenosine kinase in mammalian cells: The long isoform of AdK is localized in the nucleus. Biochem Biophys Res Commun 388: 46-50.
13. DiMauro S, Andreu AL, De Vivo DC. 2002. Mitochondrial disorders. J Child Neurol 17(Suppl 3): 3S35-3S45; discussion 3S46-3S47.
14. Dunwiddie TV. 1980. Endogenously released adenosine regulates excitability in the in vitro hippocampus. Epilepsia 21: 541-548.
15. During MJ, Spencer DD. 1992. Adenosine: A potential mediator of seizure arrest and postictal refractoriness. Ann Neurol 32: 618-624.
16. Ekonomou A, Sperk G, Kostopoulos G, Angelatou F. 2000. Reduction of A1 adenosine receptors in rat hippocampus after kainic acid-induced limbic seizures. Neurosci Lett 284: 49-52.
17. Etherington LA, Patterson GE, Meechan L, Boison D, Irving AJ, Dale N, Frenguelli B. 2009. Astrocytic adenosine kinase regulates basal synaptic adenosine levels and seizure activity but not activity-dependent adenosine release in the hippocampus. Neuropharmacology 56: 429-437.
18. Fedele DE, Koch P, Brüstle O, Scheurer L, Simpson EM, Mohler H, Boison D. 2004. Engineering embryonic stem cell derived glia for adenosine delivery. Neurosci Lett 370: 160-165.
19. 1 receptors are crucial in keeping an epileptic focus localized. Exp Neurol 200: 184-190.
20. Fiebich BL, Biber K, Lieb K, van Calker D, Berger M, Bauer J, Gebicke-Haerter PJ. 1996. Cyclooxygenase-2 expression in rat microglia is induced by adenosine A2a-receptors. Glia 18: 152-160.
21. Fredholm BB, Chen JF, Cunha RA, Svenningsson P, Vaugeois JM. 2005a. Adenosine and brain function. Int Rev Neurobiol 63: 191-270.
22. Fredholm BB, Chen JF, Masino SA, Vaugeois JM. 2005b. Actions of adenosine at its receptors in the CNS: Insights from knockouts and drugs. Annu Rev Pharmacol Toxicol 45: 385-412.
23. Fredholm BB, Hedqvist P. 1980. Modulation of neurotransmission by purine nucleotides and nucleosides. Biochem Pharmacol 29: 1635-1643.
24. Fredholm BB, Ijzerman AP, Jacobson KA, Linden J, Muller CE. 2011. International union of basic and clinical pharmacology. LXXXI. Nomenclature and classification of adenosine receptors--An update. Pharmacol Rev 63: 1-34.
25. Gebicke-Haerter PJ, Christoffel F, Timmer J, Northoff H, Berger M, Van Calker D. 1996. Both adenosine A1- and A2-receptors are required to stimulate microglial proliferation. Neurochem Int 29: 37-42.
26. Geiger JD, Nagy JI. 1986. Distribution of adenosine deaminase activity in rat brain and spinal cord. J Neurosci 6: 2707-2714.
27. Glass M, Faull RL, Bullock JY, Jansen K, Mee EW, Walker EB, Synek BJ, Dragunow M. 1996. Loss of A1 adenosine receptors in human temporal lobe epilepsy. Brain Res 710: 56-68.
28. 1 receptor activation in a mouse model of pharmacoresistant epilepsy. Epilepsia 44: 877-885.
29. Gouder N, Scheurer L, Fritschy J-M, Boison D. 2004. Overexpression of adenosine kinase in epileptic hippocampus contributes to epileptogenesis. J Neurosci 24: 692-701.
30. 1 receptor desensitization after focal long-term delivery of adenosine by encapsulated myoblasts. Exp Neurol 193: 53-64.
31. Halassa MM, Haydon PG. 2010. Integrated brain circuits: Astrocytic networks modulate neuronal activity and behavior. Annu Rev Physiol 72: 335-355.
32. Hanson EA. 2009. Can adenosine substitute for SAM-e as an adjunct in the treatment of depression? Med Hypotheses 73: 857-859.
33. Hasko G, Pacher P, Vizi ES, Illes P. 2005. Adenosine receptor signaling in the brain immune system. Trends Pharmacol Sci 26: 511-516.
34. Hermann B, Seidenberg M, Jones J. 2008. The neurobehavioural comorbidities of epilepsy: Can a natural history be developed? Lancet Neurol 7: 151-160.
35. Hindley S, Herman MA, Rathbone MP. 1994. Stimulation of reactive astrogliosis in vivo by extracellular adenosine diphosphate or an adenosine A2 receptor agonist. J Neurosci Res 38: 399-406.
36. Huber A, Padrun V, Deglon N, Aebischer P, Mohler H, Boison D. 2001. Grafts of adenosine-releasing cells suppress seizures in kindling epilepsy. Proc Natl Acad Sci USA 98: 7611-7616.
37. Jacobson KA, Gao ZG. 2006. Adenosine receptors as therapeutic targets. Nat Rev Drug Discov 5: 247-264.
38. Kang J, Kang N, Lovatt D, Torres A, Zhao Z, Lin J, Nedergaard M. 2008. Connexin 43 hemichannels are permeable to ATP. J Neurosci 28: 4702-4711.
39. Kobow K, Blumcke I. 2011. The methylation hypothesis: Do epigenetic chromatin modifications play a role in epileptogenesis? Epilepsia 52(Suppl 4): 15-19.
40. Kochanek PM, Vagni VA, Janesko KL, Washington CB, Crumrine PK, Garman RH, Jenkins LW, Clark RS, Homanics GE, Dixon CE, Schnermann JA, Jackson EK. 2006. Adenosine A1 receptor knockout mice develop lethal status epilepticus after experimental traumatic brain injury. J Cereb Blood Flow Metab 26: 565-575.
41. Kossoff EH, Rho JM. 2009. Ketogenic diets: Evidence for short- and long-term efficacy. Neurotherapeutics 6: 406-414.
42. Kunz WS. 2002. The role of mitochondria in epileptogenesis. Curr Opin Neurol 15: 179-184.
43. Latini S, Pedata F. 2001. Adenosine in the central nervous system: Release mechanisms and extracellular concentrations. J Neurochem 79: 463-484.
44. Lewin E, Bleck V. 1985. Effect of inosine on seizures induced with pentylenetetrazole, bicuculline, or picrotoxin. Epilepsia 26: 258-261.
45. Li T, Lan JQ, Fredholm BB, Simon RP, Boison D. 2007a. Adenosine dysfunction in astrogliosis: Cause for seizure generation? Neuron Glia Biol 3: 353-366.
46. Li T, Lytle N, Lan J-Q, Sandau US, Boison D. 2012. Local disruption of glial adenosine homeostasis in mice associates with focal electrographic seizures: A first step in epileptogenesis? Glia 60: 83-95.
47. Li T, Ren G, Lusardi T, Wilz A, Lan JQ, Iwasato T, Itohara S, Simon RP, Boison D. 2008. Adenosine kinase is a target for the prediction and prevention of epileptogenesis in mice. J Clin Invest 118: 571-582.
48. Li T, Steinbeck JA, Lusardi T, Koch P, Lan JQ, Wilz A, Segschneider M, Simon RP, Brustle O, Boison D. 2007b. Suppression of kindling epileptogenesis by adenosine releasing stem cell-derived brain implants. Brain 130: 1276-1288.
49. Masino SA, Geiger JD. 2008. Are purines mediators of the anticonvulsant/neuroprotective effects of ketogenic diets? Trends Neurosci 31: 273-278.
50. Masino SA, Kawamura M, Ruskin DN, Geiger JD, Boison D. 2011a. Purines and neuronal excitability: Links to the ketogenic diet. Epilepsy Res [Epub ahead of print].
51. Masino SA, Li T, Theofilas P, Sandau US, Ruskin DN, Fredholm BB, Geiger JD, Aronica E, Boison D. 2011b. A ketogenic diet suppresses seizures in mice through adenosine A1 receptors. J Clin Inv 121: 2679-2683.
52. Mato JM, Martinez-Chantar ML, Lu SC. 2008. Methionine metabolism and liver disease. Ann Rev Nutr 28: 273-293.
53. McGaraughty S, Cowart M, Jarvis MF, Berman RF. 2005. Anticonvulsant and antinociceptive actions of novel adenosine kinase inhibitors. Curr Top Med Chem 5: 43-58.
54. Newby AC, Worku Y, Holmquist CA. 1985. Adenosine formation. Evidence for a direct biochemical link with energy metabolism. Adv Myocardiol 6: 273-284.
55. Oro J. 1961. Mechanism of synthesis of adenine from hydrogen cyanide under possible primitive earth conditions. Nature 191: 1193-1194.
56. Pak MA, Haas HL, Decking UKM, Schrader J. 1994. Inhibition of adenosine kinase increases endogenous adenosine and depresses neuronal activity in hippocampal slices. Neuropharmacol 33: 1049-1053.
57. Palchykova S, Winsky-Sommerer R, Shen H-Y, Boison D, Gerling A, Tobler I. 2010. Manipulation of adenosine kinase affects sleep regulation in mice. J Neurosci 30: 13157-13165.
58. Pascual O, Casper KB, Kubera C, Zhang J, Revilla-Sanchez R, Sul JY, Takano H, Moss SJ, McCarthy K, Haydon PG. 2005. Astrocytic purinergic signaling coordinates synaptic networks. Science 310: 113-116.
59. Phillips E, Newsholme EA. 1979. Maximum activities, properties and distribution of 5' nucleotidase, adenosine kinase and adenosine deaminase in rat and human brain. J Neurochem 33: 553-558.
60. Pignataro G, Maysami S, Studer FE, Wilz A, Simon RP, Boison D. 2008. Downregulation of hippocampal adenosine kinase after focal ischemia as potential endogenous neuroprotective mechanism. J Cereb Blood Flow Metab 28: 17-23.
61. Pignataro G, Simon RP, Boison D. 2007. Transgenic overexpression of adenosine kinase aggravates cell death in ischemia. J Cereb Blood Flow Metab 27: 1-5.
62. Ravizza T, Gagliardi B, Noe F, Boer K, Aronica E, Vezzani A. 2008. Innate and adaptive immunity during epileptogenesis and spontaneous seizures: Evidence from experimental models and human temporal lobe epilepsy. Neurobiol Dis 29: 142-160.
63. Ren G, Li T, Lan JQ, Wilz A, Simon RP, Boison D. 2007. Lentiviral RNAi-induced downregulation of adenosine kinase in human mesenchymal stem cell grafts: A novel perspective for seizure control. Exp Neurol 208: 26-37.
64. Ribeiro JA. 2005. What can adenosine neuromodulation do for neuroprotection? Curr Drug Targets CNS Neurol Disord 4: 325-329.
65. Rosengren LE, Ahlsen G, Belfrage M, Gillberg C, Haglid KG, Hamberger A. 1992. A sensitive ELISA for glial fibrillary acidic protein: Application in CSF of children. J Neurosci Methods 44: 113-119.
66. Saura J, Angulo E, Ejarque A, Casado V, Tusell JM, Moratalla R, Chen JF, Schwarzschild MA, Lluis C, Franco R, et al. 2005. Adenosine A2A receptor stimulation potentiates nitric oxide release by activated microglia. J Neurochem 95: 919-929.
67. Schiffer D, Fiano V. 2004. Astrogliosis in ALS: Possible interpretations according to pathogenetic hypotheses. Amyotroph Lateral Scler Other Motor Neuron Disord 5: 22-25.
68. Sebastiao AM, Ribeiro JA. 2009. Adenosine receptors and the central nervous system. Handb Exp Pharmacol(193): 471-534.
69. Shen H-Y, Coelho JE, Ohtsuka N, Canas PM, Day Y-J, Huang Q-Y, Rebola N, Yu L, Boison D, Cunha RA, et al. 2008. A critical role of the adenosine A2A receptor in extra-striatal neurons in modulating psychomotor activity as revealed by opposite phenotypes of striatum- and forebrain-A2A receptor knockouts. J Neurosci 28: 2970-2975.
70. Shen HY, Lusardi TA, Williams-Karnesky RL, Lan JQ, Poulsen DJ, Boison D. 2011. Adenosine kinase determines the degree of brain injury after ischemic stroke in mice. J Cereb Blood Flow Metab 31: 1648-1659.
71. Stone TW, Ceruti S, Abbracchio MP. 2009. Adenosine receptors and neurological disease: Neuroprotection and neurodegeneration. Handb Exp Pharmacol 193: 535-587.
72. Studer FE, Fedele DE, Marowsky A, Schwerdel C, Wernli K, Vogt K, Fritschy JM, Boison D. 2006. Shift of adenosine kinase expression from neurons to astrocytes during postnatal development suggests dual functionality of the enzyme. Neuroscience 142: 125-137.
73. Szybala C, Pritchard EM, Wilz A, Kaplan DL, Boison D. 2009. Antiepileptic effects of silk-polymer based adenosine release in kindled rats. Exp Neurol 219: 126-135.
74. Theofilas P, Brar S, Stewart K-A, Shen H-Y, Sandau US, Poulsen DJ, Boison D. 2011. Adenosine kinase as a target for therapeutic antisense strategies in epilepsy. Epilepsia 52: 589-601.
75. Uva L, Librizzi L, Marchi N, Noe F, Bongiovanni R, Vezzani A, Janigro D, de Curtis M. 2008. Acute induction of epileptiform discharges by pilocarpine in the in vitro isolated guinea-pig brain requires enhancement of blood-brain barrier permeability. Neuroscience 151: 303-312.
76. Van Eldik LJ, Griffin WS. 1994. S100 beta expression in Alzheimer's disease: Relation to neuropathology in brain regions. Biochim Biophys Acta 1223: 398-403.
77. Vezzani A, Ravizza T, Balosso S, Aronica E. 2008. Glia as a source of cytokines: Implications for neuronal excitability and survival. Epilepsia 49(Suppl 2): 24-32.
78. Wilz A, Pritchard EM, Li T, Lan JQ, Kaplan DL, Boison D. 2008. Silk polymer-based adenosine release: Therapeutic potential for epilepsy. Biomaterials 29: 3609-3616.
79. Yee BK, Singer P, Chen JF, Feldon J, Boison D. 2007. Transgenic overexpression of adenosine kinase in brain leads to multiple learning impairments and altered sensitivity to psychomimetic drugs. Eur J Neurosci 26: 3237-3252.
80. Zhang W, Wang J, Wang H, Tang R, Belcher JD, Viollet B, Geng JG, Zhang C, Wu C, Slungaard A, et al. 2010. Acadesine inhibits tissue factor induction and thrombus formation by activating the phosphoinositide 3-kinase/Akt signaling pathway. Arterioscler Thromb Vasc Biol 30: 1000-1006.